PRTN3 and rheumatoid arthritis: We have also shown that Anti-CarP antibodies are present in arthralgia patients and that their presence predicts the development of RA, independent of the patient's ACPA status, indicating that anti-CarP might also be useful as a biomarker for seronegative RA [15].